Docetaxel and Bortezomib in Treating Patients With Progressive or Recurrent Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Non-small Cell Lung Cancer
Related studies linked through entity extraction aliases.
Study of BMS-275183 in Patients With Pretreated Locally Advanced or Metastatic NSCLC (Non Small Cell Lung Cancer)
- Status
- TERMINATED
- Phase
- PHASE2
Docetaxel & Oxaliplatin in Combination With Bevacizumab as First-Line Treatment in Subjects With Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 2 Study Evaluating ABT-751 in Combination With Taxotere in Advanced Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Safety Evaluation of Panitumumab and Sirolimus in Advanced Non-Small Cell Lung Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
Lung Tumour Volume Database
- Status
- COMPLETED
- Phase
- N/A
Phase I/II Trial of Bevacizumab, Pemetrexed and Erlotinib in Elderly Patients With Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study of Alimta® (Pemetrexed) Plus VELCADE® (Bortezomib) or Alimta Alone or VELCADE Alone in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Prior Therapy
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Cetuximab and Bevacizumab in Combination With Paclitaxel and Carboplatin in Stage IIIb/IV NSCLC
- Status
- COMPLETED
- Phase
- PHASE2
Prevention of Tumor Spread Due to Lung Cancer Surgery
- Status
- COMPLETED
- Phase
- N/A
First-Line EGFR-1 Tyrosine Kinase Inhibition in Patients With NSCLC With Mutant EGFR Gene
- Status
- UNKNOWN
- Phase
- PHASE2
Phase II Iressa + Irradiation Followed by Chemo in NSCLC
- Status
- COMPLETED
- Phase
- PHASE2
Safety Study of Imexon Plus Docetaxel in Lung, Breast or Prostate Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE1
A Study of MORAb-009 in Subjects With Pancreatic Cancer, Mesothelioma, or Certain Types of Ovarian or Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
First Line IRESSA™ Versus Carboplatin/Paclitaxel in Asia
- Status
- COMPLETED
- Phase
- PHASE3
Survival Study of Docetaxel and Carboplatin as Neo-Adjuvant Vs Adjuvant Chemotherapy in Early Stage NSLC
- Status
- COMPLETED
- Phase
- PHASE3
Second-Line Irinotecan or Gefitinib in Docetaxel Pretreated NSCLC
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of Bevacizumab Plus Carboplatin and Paclitaxel in Subjects With Advanced, Previously Untreated, Squamous Non-Small Cell Lung Cancer (BRIDGE)
- Status
- COMPLETED
- Phase
- PHASE2
Study of Pemetrexed in Mesothelioma and Lung Cancer Patients With Fluid Around the Lungs or Abdomen
- Status
- COMPLETED
- Phase
- PHASE2
Initial Assessment of the Effect of the Addition of Disulfiram (Antabuse) to Standard Chemotherapy in Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3